Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Close this folder7. The editorial process
View the document7.1 Outline of the editorial process
Open this folder and view contents7.2 Editing a drug bulletin
Open this folder and view contents7.3 Writing bulletin articles
Close this folder7.4 Reviewing the article
View the document7.4.1 How many people should review an article?
View the document7.4.2 Should a bulletin set up a permanent review board?
View the document7.4.3 Should readers be included in the review board?
View the document7.4.4 Should patients or lay people be included?
View the document7.4.5 Should the pharmaceutical industry review drafts?
View the document7.4.6 Tips for reviewing articles
View the document7.4.7 Rewarding reviewers
View the document7.5. Rewriting the article
View the document7.6 Final checks
Open this folder and view contents7.7 Follow-up after publication
View the document7.8 References
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

7.4.6 Tips for reviewing articles

Whatever the size of the review board, these are some recommendations for the review process:

• circulate anonymous drafts. This greatly facilitates criticism. Some bulletins also do not name the editor and some inform reviewers that their comments will be kept confidential;

• try to get people with different therapeutic opinions to review a draft. It is always useful to find out why people may disagree with your conclusions;

• use the review process to involve specialists or health professionals in the bulletin's development and to identify future editors or authors;

• reinforce links with readers by involving them as reviewers;

• provide guidelines to reviewers explaining what you expect of them and how to present their comments (e.g. you can ask them to back their comments on scientific evidence with specific references);

• monitor the performance of reviewers.


The more effective reviewers you involve, the more difficult management becomes if you want them to receive feedback in order to maintain motivation. Electronic reviewing (e-mail) is, for example, used by the Dutch bulletin Geneesmiddelenbulletin to help simplify this process. However, the same amount of time and competence are needed to produce a careful evaluation of reviewers’ comments whether they arrive in the post or electronically.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014